Dr. Jason Gleghorn, Associate Professor of Biomedical Engineering at the University of Delaware, is pioneering the development of microfluidic organ-on-a-chip models that are compact—approximately the size of two postage stamps—and cost-effective. These devices replicate human organ systems, enabling more accurate disease modeling and drug testing compared to traditional animal models. Dr. Gleghorn’s innovation aims to democratize access to advanced biomedical research tools by simplifying manufacturing processes, making them accessible to non-experts. His research focuses on areas such as women’s health, maternal-fetal health, and pre-term birth, with broader implications for understanding drug transport in various human tissues. Supported in part by the NSF-funded Accelerating Research Translation (ART) program, Dr. Gleghorn is committed to translating his research into practical applications that benefit public health while mentoring the next generation of scientists at the intersection of research and entrepreneurship. Read more about his work here.